Literature DB >> 35838960

Identification of Circulating Biomarkers of COVID-19 Using MALDI-TOF Mass Spectrometry.

Lucas C Lazari1, Livia Rosa-Fernandes1, Giuseppe Palmisano2.   

Abstract

Matrix-assisted laser desorption/ionization source coupled with time-of-flight mass analyzer mass spectrometry (MALDI-TOF MS) is being widely used to obtain proteomic profiles for clinical purposes, as a fast, low-cost, robust, and efficient technique. Here we describe a method for biofluid analysis using MALDI-TOF MS for rapid acquisition of proteomic signatures of COVID-19 infected patients. By using solid-phase extraction, the method allows the analysis of biofluids in less than 15 min.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Biofluids; COVID-19; MALDI-TOF; Proteomics

Mesh：

Substances：

Year:  2022        PMID： 35838960     DOI： 10.1007/978-1-0716-2395-4_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


  7 in total

1.  Direct identification of trypanosomatids by matrix-assisted laser desorption ionization-time of flight mass spectrometry (DIT MALDI-TOF MS).

Authors:  C C Avila; F G Almeida; G Palmisano
Journal:  J Mass Spectrom       Date:  2016-08       Impact factor: 1.982

2.  Superiority of MALDI-TOF Mass Spectrometry over Real-Time PCR for SARS-CoV-2 RNA Detection.

Authors:  Magda Rybicka; Ewa Miłosz; Krzysztof Piotr Bielawski
Journal:  Viruses       Date:  2021-04-22       Impact factor: 5.048

3.  An automated plasma protein fractionation design: high-throughput perspectives for proteomic analysis.

Authors:  Claudia Boccardi; Silvia Rocchiccioli; Antonella Cecchettini; Alberto Mercatanti; Lorenzo Citti
Journal:  BMC Res Notes       Date:  2012-11-01

4.  Esterase D and gamma 1 actin level might predict results of induction therapy in patients with acute myeloid leukemia without and with maturation.

Authors:  Maciej Kaźmierczak; Magdalena Luczak; Krzysztof Lewandowski; Luiza Handschuh; Anna Czyż; Małgorzata Jarmuż; Michał Gniot; Michał Michalak; Marek Figlerowicz; Mieczysław Komarnicki
Journal:  Med Oncol       Date:  2013-10-02       Impact factor: 3.064

5.  A combined approach of MALDI-TOF mass spectrometry and multivariate analysis as a potential tool for the detection of SARS-CoV-2 virus in nasopharyngeal swabs.

Authors:  María Florencia Rocca; Jonathan Cristian Zintgraff; María Elena Dattero; Leonardo Silva Santos; Martín Ledesma; Carlos Vay; Mónica Prieto; Estefanía Benedetti; Martín Avaro; Mara Russo; Fabiane Manke Nachtigall; Elsa Baumeister
Journal:  J Virol Methods       Date:  2020-10-09       Impact factor: 2.014

6.  Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19.

Authors:  Lucas Cardoso Lazari; Fabio De Rose Ghilardi; Livia Rosa-Fernandes; Diego M Assis; José Carlos Nicolau; Veronica Feijoli Santiago; Talia Falcão Dalçóquio; Claudia B Angeli; Adriadne Justi Bertolin; Claudio Rf Marinho; Carsten Wrenger; Edison Luiz Durigon; Rinaldo Focaccia Siciliano; Giuseppe Palmisano
Journal:  Life Sci Alliance       Date:  2021-06-24

Review 7.  Current status of MALDI-TOF mass spectrometry in clinical microbiology.

Authors:  Tsung-Yun Hou; Chuan Chiang-Ni; Shih-Hua Teng
Journal:  J Food Drug Anal       Date:  2019-01-31       Impact factor: 6.157
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.